OMIC | tickerfilter.com

Fundamental analysis

20%

Profitability 0%

Dept financing 9%

Liquidity 75%

Performance 30%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.47%

1 Month

-11.64%

3 Months

24.76%

6 Months

74.32%

1 Year

55.42%

2 Year

-70.95%

Key data

Stock price

$19.42

P/E Ratio

-0.19

DAY RANGE

$19.52 - $19.52

EPS

-$37.37

52 WEEK RANGE

$5.75 - $23.41

52 WEEK CHANGE

$36.94

MARKET CAP

17.739 M

YIELD

N/A

SHARES OUTSTANDING

2.496 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/12/2024

BETA

0.00

PUBLIC FLOAT

AVERAGE 10 VOLUME

$35,127

AVERAGE 30 VOLUME

$19,252

Company detail

CEO: Andrew Spaventa
Region: US
Website: singulargenomics.com
Employees: 220
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology. The company manufactures G4 Instrument, a benchtop next generation sequencer, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument.

OMIC - Singular Genomics Systems, Inc.